Clinical Trial Update: Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis [Phase 2]

View source ↗

Summary

Phase 2 trial of doxycycline for Mansonella perstans infection (with and without lymphatic filariasis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mansonella Perstans Infection
• Mansonelliasis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mansonella Perstans Infection, Mp Microfilaremia | Phase 2 | Status: COMPLETED